BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Johnson and Johnson
Chinese Patent Office
Boehringer Ingelheim

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018421

« Back to Dashboard
NDA 018421 describes LITHIUM CITRATE, which is a drug marketed by West-ward Pharms Int and Wockhardt and is included in two NDAs. It is available from two suppliers. Additional details are available on the LITHIUM CITRATE profile page.

The generic ingredient in LITHIUM CITRATE is lithium citrate. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lithium citrate profile page.

Summary for NDA: 018421

Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 018421

Suppliers and Packaging for NDA: 018421

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
lithium citrate
SYRUP;ORAL 018421 NDA West-Ward Pharmaceuticals Corp 0054-3527 0054-3527-63 500 mL in 1 BOTTLE (0054-3527-63)
lithium citrate
SYRUP;ORAL 018421 NDA Precision Dose Inc. 68094-757 68094-757-62 3 TRAY in 1 CASE (68094-757-62) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (68094-757-59)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrengthEQ 300MG CARBONATE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Farmers Insurance
Daiichi Sankyo
Harvard Business School
Chinese Patent Office
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus